Figure 1.
SAA and IL-6 as prognostic biomarker in GCa. (A, B) The concentrations of SAA and IL-6 in health, benign and GCa. (C, D) The concentrations of SAA and IL-6 in health, FIGO I–II group And FIGO III–IV group. ****, P < .0001, **, P < .01, *, P < .05, ns, P > .05. (E) ROC curve of sensitivity versus specificity of SAA, IL-6, CEA and combinations of 3 makers. (F) A positive correlation between serum IL-6 and SAA, R2 = 0.295, P < .0001. CEA = Cancer embryonic antigen, GCa = gastric cancer, IL-6 = Interleukin-6, SAA = serum amyloid A.